Dr. Mark Joseph Gallardo , MD
Ophthalmology • El Paso, TX
959 Sunland Park Dr Ste 100
El Paso, TX 799221323
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 5, 2006; this date does not establish years in practice.
-
Published CMS data list 3,898 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92012 — Established patient problem focused exam of visual system: 861 service units.
- 76519 — Ultrasound scan to determine eye length and lens power: 483 service units.
- 92133 — Imaging of optic nerve: 479 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 9,906 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost — 1,947 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 1,485 prescription fills, including refills.
- Brimonidine Tartrate — 935 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 33 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in El Paso, TX (2024, 16 clinicians with data). Median for this group: 869. Middle half: 479 to 1,979.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,735 in 2020 to 3,898 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
959 Sunland Park Dr Ste 100
El Paso, TX 799221323
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: El Paso Eye Surgeons, P.A.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Science Center School Of Medicine
2001
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,034 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $608,197 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $445,849 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
20,220 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,437,907 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $167,915.48 across 97 records.
By nature of payment (3 largest of 5)
- Royalty or License: $102,597.65 across 4 records.
- Consulting Fee: $56,390.00 across 26 records.
- Food and Beverage: $4,763.97 across 64 records.
Reporting-company totals (3 largest of 14)
- Glaukos Corporation: $142,559.20 across 29 records.
- Nova Eye, Inc.: $10,598.02 across 2 records.
- Alcon Vision LLC: $5,762.90 across 22 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Gallardo has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Gallardo as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in El Paso, TX (2024, 16 clinicians with data). Median for this group: 869. Middle half: 479 to 1,979.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in El Paso, TX (2024, 16 clinicians with data). Median for this group: $95,193. Middle half: $61,682 to $223,463.
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in El Paso, TX (2024, 16 clinicians with data). Median for this group: $64,735. Middle half: $45,399 to $148,077.
A higher Medicare payment amount than 80% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Ophthalmology in El Paso, TX (2024, 17 clinicians with data). Median for this group: 2,041. Middle half: 185 to 4,022.
More Part D prescriptions than 95% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Ophthalmology in El Paso, TX (2024, 17 clinicians with data). Median for this group: $172,001. Middle half: $19,176 to $651,075.
A higher Part D drug cost than 95% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
30 active clinicians are listed under Ophthalmology with a practice address in El Paso, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
0% of these 30 clinicians have the CMS telehealth indicator.
60% of these 30 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 3,735 in 2020 and 3,898 in 2024.
- 2020: 3,735
- 2021: 4,431
- 2022: 3,640
- 2023: 3,319
- 2024: 3,898
-
Medicare-allowed amount
Medicare-allowed amount increased 23% from $496,448 in 2020 to $608,197 in 2024.
- 2020: $496,448
- 2021: $639,387
- 2022: $559,676
- 2023: $512,574
- 2024: $608,197
-
Paid by Medicare
Paid by Medicare increased 22% from $366,416 in 2020 to $445,849 in 2024.
- 2020: $366,416
- 2021: $476,524
- 2022: $406,235
- 2023: $379,758
- 2024: $445,849
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 9,418 in 2020 and 9,906 in 2024.
- 2020: 9,418
- 2021: 9,729
- 2022: 10,005
- 2023: 10,457
- 2024: 9,906
-
30-day fills
30-day fills increased 12% from 18,113 in 2020 to 20,220 in 2024.
- 2020: 18,113
- 2021: 18,665
- 2022: 19,633
- 2023: 20,716
- 2024: 20,220
-
Part D drug cost
Part D drug cost decreased 23% from $1,872,332 in 2020 to $1,437,907 in 2024.
- 2020: $1,872,332
- 2021: $1,893,292
- 2022: $1,878,732
- 2023: $1,949,323
- 2024: $1,437,907
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 152% from $67,135.70 in 2021 to $168,985.48 in 2025.
- 2021: $67,135.70
- 2022: $413,416.24
- 2023: $279,349.67
- 2024: $182,589.73
- 2025: $168,985.48
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 99 records totaling $168,985.48.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Glaukos Corporation |
Royalty or License
Cash or cash equivalent
|
iAccess Trabecular Trephine | General | $30,468.20 |
| Glaukos Corporation |
Royalty or License
Cash or cash equivalent
|
iAccess Trabecular Trephine | General | $24,616.85 |
| Glaukos Corporation |
Royalty or License
Cash or cash equivalent
|
iAccess Trabecular Trephine | General | $24,107.80 |
| Glaukos Corporation |
Royalty or License
Cash or cash equivalent
|
iAccess Trabecular Trephine | General | $23,404.80 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $8,400.00 |
| Nova Eye, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $8,250.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,100.00 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
Voyager DSLT | General | $3,000.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $2,875.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
Travoprost Intraocular Implant - iDose | General | $2,400.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,400.00 |
| Nova Eye, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $2,348.02 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $2,175.00 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
Voyager DSLT | General | $2,000.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $1,950.00 |
| Bausch & Lomb Americas Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,700.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,625.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,625.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,625.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,600.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
Travoprost Intraocular Implant - iDose | General | $1,600.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,600.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,250.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,250.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
iStent inject Trabecular Micro-Bypass System Model G2-M-IS | General | $1,250.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92012
Established patient problem focused exam of visual system
|
861 | 484 | $110.00 | $83.17 |
|
76519
Ultrasound scan to determine eye length and lens power
|
483 | 319 | $180.00 | $49.41 |
|
92133
Imaging of optic nerve
|
479 | 436 | $160.00 | $31.61 |
|
92083
Exam of visual field with extended testing
|
467 | 414 | $150.00 | $58.93 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
402 | 242 | $2150.00 | $445.61 |
|
92004
New patient complete exam of visual system
|
377 | 377 | $200.00 | $136.71 |
|
92014
Established patient complete exam of visual system
|
332 | 325 | $175.00 | $117.99 |
|
66991
Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye
|
76 | 54 | $3650.00 | $554.03 |
|
65855
Laser repair to improve eye fluid flow
|
65 | 46 | $1100.00 | $229.74 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
57 | 43 | $1000.00 | $304.33 |
|
92020
Exam of the internal drainage system of eye
|
40 | 40 | $150.00 | $25.28 |
|
65820
Incision to improve eye fluid flow
|
38 | 32 | $1600.00 | $765.00 |
|
0660T
Implantation of drug-releasing device in front chamber of eye
|
35 | 26 | $2500.00 | $722.35 |
|
66174
Dilation of fluid outflow drainage within eye
|
31 | 23 | $2500.00 | $401.70 |
|
92250
Photography of the retina
|
31 | 30 | $100.00 | $34.45 |
|
0671T
Insertion of drainage device into drainage tissue within eye (trabecular meshwork)
|
29 | 25 | $2500.00 | $966.50 |
|
92134
Imaging of retina
|
25 | 24 | $160.00 | $37.59 |
|
65855
Laser repair to improve eye fluid flow
|
18 | 15 | $1100.00 | $192.59 |
|
66180
Creation of shunt to improve eye fluid flow using tissue graft
|
18 | 17 | $1500.00 | $1065.37 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
17 | 14 | $1000.00 | $291.75 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
17 | 16 | $50.00 | $21.86 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 1,947 | 133,783 | $23,142.97 | 641 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 1,485 | 106,237 | $27,840.84 | 480 |
| Brimonidine Tartrate | Brimonidine Tartrate | 935 | 65,056 | $26,868.10 | 340 |
| Prednisolone Acetate | Prednisolone Acetate | 841 | 29,522 | $35,144.38 | 535 |
| Timolol Maleate | Timolol Maleate | 615 | 42,866 | $8,990.69 | 248 |
| Moxifloxacin | Moxifloxacin Hcl | 592 | 10,837 | $23,149.94 | 441 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 470 | 30,105 | $87,759.70 | 181 |
| Dorzolamide Hcl | Dorzolamide Hcl | 374 | 26,278 | $8,667.49 | 142 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 366 | 16,118 | $10,179.98 | 290 |
| Vyzulta | Latanoprostene Bunod | 358 | 19,781 | $187,703.07 | 101 |
| Rhopressa | Netarsudil Mesylate | 327 | 16,330 | $198,866.82 | 105 |
| Lumigan | Bimatoprost | 288 | 18,152 | $163,443.65 | 97 |
| Combigan | Brimonidine Tartrate/Timolol | 220 | 12,506 | $96,802.90 | 81 |
| Travoprost | Travoprost | 145 | 7,813 | $18,830.83 | 45 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 140 | 8,382 | $118,895.63 | 56 |
| Xiidra | Lifitegrast | 118 | 7,860 | $175,403.82 | 45 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 87 | 5,212 | $30,366.55 | 33 |
| Restasis | Cyclosporine | 82 | 4,350 | $84,716.93 | 37 |
| Brinzolamide | Brinzolamide | 76 | 4,960 | $11,145.95 | 26 |
| Methazolamide | Methazolamide | 67 | 2,879 | $13,425.70 | 33 |
| Alphagan P | Brimonidine Tartrate | 58 | 3,465 | $29,738.01 | 23 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 48 | 2,925 | $8,377.85 | 11 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 42 | 710 | $640.93 | 31 |
| Atropine Sulfate | Atropine Sulfate | 33 | 1,683 | $1,250.11 | 17 |
| Cyclopentolate Hcl | Cyclopentolate Hcl | 32 | 1,085 | $550.32 | 17 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-11-21NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20140417001310
NM
5890726012
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
El Paso Eye Surgeons, P.a.
959 Sunland Park Dr, El Paso, TX 799221323
Phone: 9155420279
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 959 SUNLAND PARK DR STE 100, EL PASO, TX 799221323 (Tel: 9155420279)
Registered at 959 SUNLAND PARK DR STE 100, EL PASO, TX 799221323 (Tel: 9155420279)
NPI status registered as active in NPPES database
Registered at 4801 ALBERTA AVE., EL PASO, TX 79905 (Tel: 9155459795)
Registered at PO BOX 9520, EL PASO, TX 799959520 (Tel: 9155459795)
Recorded as MARK GALLARDO, M.D.
Ophthalmology (license number reported to NPPES: TX M1100)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in El Paso
- Dr. Michael Foote, MD
- Dr. Robert Maddox, MD
- Dr. Sapna Tibrewal, MD
- Dr. Keak Khauv, MD
- Claudia Prospero Ponce
- Samuel Faith, MDMPH
Mailing Address
959 Sunland Park Dr Ste 100
El Paso, TX 799221323
Phone: 9155420279